Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Radiation-Sensitizing Agents

Known as: Agents, Radiation-Sensitizing, Radiation Sensitizing Drugs, Radiosensitizing Drugs 
Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
National Institutes of Health

Related topics

Related topics

49 relations

Narrower (39)

3-aminobenzamide4-nitroacetophenoneAfatinibBromodeoxyuridine
Expand

Broader (1)

Pharmaceutical Preparations
RadiationRadiation ToleranceRadiation-Sensitizing EffectStaurosporine
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Hypoxic radiosensitization: adored and ignored.
  • J. Overgaard
  • Journal of clinical oncology : official journal…
  • 2007
    • Corpus ID: 676499
Since observations from the beginning of the last century, it has become well established that solid tumors may contain oxygen… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2006
Highly Cited
2006
High molar extinction coefficient heteroleptic ruthenium complexes for thin film dye-sensitized solar cells.
Two novel heteroleptic sensitizers, Ru((4,4-dicarboxylic acid-2,2'-bipyridine)(4,4'-bis(p-hexyloxystyryl)-2,2-bipyridine)(NCS)2… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Review
2002
Review
2002
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Poly(ADP-ribose) polymerase-1 (PARP-1) is a member of the PARP enzyme family consisting of PARP-1 and several recently identified… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Highly Cited
1999
Highly Cited
1999
Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
Caffeine exposure sensitizes tumor cells to ionizing radiation and other genotoxic agents. The radiosensitizing effects of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1999
Highly Cited
1999
Metal complexes as photo- and radiosensitizers.
Review
1998
Review
1998
Bladder cancer.
  • H. Ozen
  • Current opinion in oncology
  • 1998
    • Corpus ID: 821024
Identification of genetic alterations in bladder cancer is proceeding very rapidly. The most common genetic alteration identified… Expand
Highly Cited
1998
Highly Cited
1998
Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.
Members of the phosphatidylinositol-3 kinase related kinase (PIKK) family function in both cell cycle progression and DNA damage… Expand
  • figure I
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1993
Highly Cited
1993
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.
BACKGROUND Despite notable technical advances in therapy for malignant gliomas during the past decade, improved patient survival… Expand
Review
1984
Review
1984
The relevance of tumour pH to the treatment of malignant disease.
The wide range of tumour pH values that have been determined in human tumours is shown in Fig. 4. It can be seen that tumour pH… Expand
  • table I
  • table II
  • table II
  • figure 2
  • figure 3
Highly Cited
1981
Highly Cited
1981
Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.
The cytotoxicities of a number of antineoplastic agents to oxygenated and hypoxic EMT6 mouse mammary tumor cells in culture were… Expand
  • table 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE